"Reasonable compromise" to define the quality standards of platelet concentrate for non-transfusion use (CPunT)

Transfusion and Apheresis Science

Volumn 47, Issue 2, 2012, Pages 207-211

  Mazzucco, Laura ^a   Balbo, Valeria ^a   Guaschino, Roberto ^a  

^a Hospital SS Antonio e Biagio Alessandria   (Italy)

Author keywords

CPunT; Platelet; Qualification

Indexed keywords

ADHESIVE AGENT; ANGIOGENIC FACTOR; BLOOD CLOTTING FACTOR; CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; FIBRINOLYTIC AGENT; GROWTH FACTOR; MEMBRANE PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; THROMBOCYTE CONCENTRATE;

ANGIOGENESIS; BIOAVAILABILITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; FIBRIN CLOT; HEMOSTASIS; IMMUNITY; MITOGENESIS; PRODUCT DEVELOPMENT; QUALITY CONTROL; REVIEW; WOUND HEALING;

BLOOD COMPONENT TRANSFUSION; BLOOD PLATELETS; HUMANS; PLATELET COUNT;

EID: 84865444113     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.06.006     Document Type: Review

References (40)

1. Guide to preparation, use and quality assurance of blood components. 14th ed. EDQM 2008.
2. Zapata M.J., Carvajal A.M., Solà I., Bolibar I., Exposito A.J., Rodriguez L., et al. Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systemic review. Transfusion 2009, 49(1):44-56.
3. Borzini P., Mazzucco L. Tissue regeneration and in-loco administration of platelet derivatives. Clinical outcome, heterogeneous products, heterogeneity of the effector mechanisms. Transfusion 2005, 45:1759-1767.
4. Atala A. Regenerative medicine strategies. J Pediatr Surg 2012, 47(1):17-28.
5. Andia I., Sancez M., Maffulli N. Tendon healing and platelet-rich plasma therapies. Exper Opin Biol Ther 2010, 10(10):1415-1426.
6. D. Ministery of Health March the 3d 2005.
7. Blair P., Flaumenhalf R. Platelet alpha- granules: basic biology and clinical correlates. Blood 2009, 23:177-189.
8. Maynard D.M., Heijnen H.F.G., Horme M.K., et al. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007, 5:1945-1955.
9. Nurden A.T. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011, 105(Suppl. 1):S13-S33.
10. Cipriani V., Ranzato E., Balbo V., Mazzucco L., Cavaletto M., Patrone M. Long term effect of platelet lysate on fibroblasts highlighted with a proteomic approach. J Tissue Eng Regen Med 2009, 3(7):531-538.
11. Tang Y.Q., Yeaman M.R., Selsted M.E. Antimicrobial peptides from human platekets. Infect Immun 2002, 70:6524-6533.
12. May A.E., Seizer P., Gawaz M. Platelets: infiammatory firebugs of vascular walla. Atherioscler Thromb Vasc biol 2008, 28:s5-s10.
13. Pipili-Synetos E., Papadimitriou E., Maragoudakis M.E. Evidence that platelets promote tube formation by endhotelial cell on matrigel. Br J Pharmacol 1998, 125:1252-1257.
14. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2008, 13:3532-3548.
15. Bikfalvi A. Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system. Biochem Pharmacol 2004, 168:1017-1021.
16. Perroll C., Han Z.C., Savona C., Caen J.P., Bikfalvi A. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerizzation. Blood 1998, 91:3289-3299.
17. Mazzucco L., Borzini P., Gope R. Platelet derived factors involved in tissue repair from signal to function. Transfus Med Rev 2010, 24(3):218-234.
18. Greppi N., Mazzucco L., Galetti G., Bona F., Petrillo E., Smacchia C., et al. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals 2011, 39(2):73-80.
19. Zimmermann R., Arnold D., Strasser E., Ringwald J., Schlegel A., Wiltfang J., et al. Sample preparation technique and white cell content influence the detectable levels of growth factor in platelet concentrate. Vox Sang 2003, 85:283-289.
20. Borzini P., Mazzucco L., Giampaolo A., Hassan J. Platelet gel - the italian way. Call for procedure standardization and quality control. Transfusion Med 2006, 16:303-330.
21. Eppley B.L., Woodell J.E., Higgins J. Platelet quantification and growth factor analysis from platelet rich plasma: implications for wound healing. Plast Reconstr Surg 2004, 114:1502-1508.
22. Christgau M., Moder D., Hiller K.A., Dada A., Schmitz G., Schmalz G. Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J Clin Peridontol 2006, 33:837-845.
23. Weibrich G., kleis W.K.G., Hafner G., Hitzel W.E. Growth factor levels in platelet rich plasma and correlation with donor age, sex and platelet count. J Cranio Maxillofacial Surg 2002, 30:97-102.
24. Borzini P., Mazzucco L. Platelet rich plasma (PRP) and platelet derivatives for topical therapy. What is true from biologic view point?. ISBT Sci Series 2007, 2:272-281.
25. Everts P., Mahoney C., Hoffmann J., Schonberger J., Box H., Van Zundert A., et al. Platelet rich Plasma preparation using three device. Implications for platelet activation and platelet growth factors realese. Groth Factors 2006, 24(3):165-171.
26. Mazzucco L., Balbo V., Cattana E., Guaschino R., Borzini P. Not every PRP-gel is born equal evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet (R), Regen PRP-Kit (R), Plateltex (R) and one manual procedure. Vox Sang 2009, 97(2):110-118.
27. Su C.Y., Kuo Y.P., Nieh H.L., Tseng Y.H., Burnouf T. Quantitative assessment of the kinetics of growth factors release from platelet gel. Transfusion 2008, 48:2414-2420.
28. Mazzucco L., Balbo V., Cattana E., Borzini P. PRP and platelet gel preparation using Plateltex®. Vox Sang 2008, 94-209.
29. Perseghin P., Sciorelli G., Bellotti D., Speranza T., Pogliani E.M., Ferro O., et al. Frozen and thawed allogenic platelet gels for treatining postoperative chronic wound. Transfusion 2005, 45(9):1544-1546.
30. Marx R.E. Platelet rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004, 62(4):489-496.
31. Dohan Ehrenfest D.M., Bielecki T., Mishra A., Borzini P., Inchingolo F., Sammartino G., et al. In search of a consensus terminology in the field of platelet concentrates for surgical use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol 2012, 13(7):1131-1137.
32. Borzini P., Balbo V., Mazzucco L. Platelet concentrates for topical use: bedside device and blood transfusion technology. Quality and Versatility. Curr Pharm Biotechnol 2012, 13(7):1138-1144.
33. Volpi P., Quaglia A., Schoenhuber H., Melegati G., Corsi M.M., Banfi G., et al. Growth factors in the management of sport- induced tendinopathies: results after 24months from treatment. A pilot study. J Sports Med Phys Fitness 2010, 50:494-500.
34. De Leon J.M., Driver V.R., Fylling C.P., Carter M.J., Anderson C., Wilson J. The clinical relevance of treating chronic wounds with an enhanced near- physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 2011, 24(8):357-368.
35. Vidriero E.L., Krista A., Goulding A., Simon D., Sanchez M., Johnson D. The use of Platelet Rich Plasma in artroscopy and sports medicine: optimizing the healing environment. Artroscopy 2010, 26:269-278.
36. Weibrich G., Hausen T., Kleis W., Busch R., Hitzler W.E. Effect of platelet concentration in platelet rich plasma on per-implant bone regeneration. Bone 2004, 34:665-671.
37. Re Marx. Platelet-Rich Plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001, 10(4):225-228.
38. Giusti I., Rughetti A., D'Ascenzo S., Millimaggi D., Pavan A., Dell'Orso L., et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endhothelial cells. Transfusion 2009, 49:771-778.
39. Bielecki T., Dohan Ehrenfest D.M., Everts P.A., Wiczkowski A. The role of leukocytes from L-PRP/L_PRF in wound healing and immune defense. New Perspectives. Curr Pharm Biotechnol 2012, 13(7):1153-1162.
40. Dohan Ehrenfest D.M., Bielecki T., Jimbo R., Barbé G., Del Corso M., Inchingolo F., et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 2012, 13(7):1145-1152.